February 8, 2018 / 10:09 PM / 4 months ago

BRIEF-Rexahn Pharmaceuticals Says Co,Next BT Co Ltd Terminated Some Research Collaboration Agreement On RX-0201 Clinical Development Dated Feb 6, 2003

Feb 8 (Reuters) - Rexahn Pharmaceuticals Inc:

* REXAHN PHARMACEUTICALS-ON FEB 5,CO,NEXT BT CO. LTD TERMINATED SOME RESEARCH COLLABORATION AGREEMENT ON RX-0201 CLINICAL DEVELOPMENT DATED FEB 6, 2003

* REXAHN PHARMACEUTICALS - THE TERMINATED AGREEMENT DATED AS OF FEBRUARY 6, 2003, IS BY & BETWEEN CO AND REXGENE BIOTECH

* REXAHN - IN TERMINATED AGREEMENT, REXGENE AGREED TO ASSIST CO IN RESEARCH,DEVELOPMENT &CLINICAL TRIALS NECESSARY FOR REGISTRATION IN ASIA OF RX-0201

* REXAHN - TERMINATED AGREEMENT WAS TERMINATED TO ALLOW CO TO TRANSITION TO A NEW DEVELOPMENT STRATEGY FOR RX-0201 & OTHER DRUG CANDIDATES AMONG OTHERS Source text: [bit.ly/2EtkwFz] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below